← Back to Clinical Trials
Recruiting NCT07433153

NCT07433153 Comparison of Smartphone and Community-Based Delivery of the Otago Exercise Program for Fall Risk in Older Adults

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07433153
Status Recruiting
Phase —
Sponsor Binghamton University
Condition Frail Elderly
Study Type INTERVENTIONAL
Enrollment 36 participants
Start Date 2026-02-16
Primary Completion 2026-12-01

Eligibility & Interventions

Sex All sexes
Min Age 55 Years
Max Age N/A
Study Type INTERVENTIONAL
All Conditions
Interventions
Smartphone-Based InterventionGroup-Based Intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 36 participants in total. It began in 2026-02-16 with a primary completion date of 2026-12-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The long-term goal of this project is to effectively bridge the research-clinic-community gap and to foster partnerships that support the implementation, utilization, and advocacy of evidence-based fall prevention programs in the older adult community. The Otago Exercise Program (OEP) is an evidence-based fall prevention program that has been shown to reduce falls and fall-related injuries among older adults. Traditionally, OEP is delivered in the home by a physical therapist and focuses on muscle strengthening and balance training. Despite its proven effectiveness, adherence and compliance rates have been low. The personnel and resource demands of program delivery, along with challenges in monitoring participant adherence, represent significant barriers to broader implementation. Alternative delivery systems using remote and community-based platforms may help address these limitations. Specific Aim 1: To compare the effectiveness of two delivery modes of the Otago Exercise Program: a remotely delivered, home-based smartphone program and an in-person, community-based program. Specific Aim 2: To examine the feasibility, acceptability, and usability of the Otago Exercise Program delivered through both smartphone-based and in-person formats.

Eligibility Criteria

Inclusion Criteria: * Community-dwelling older adults 55 years of age or older * Communicate in English * Able to ambulate at least 10 meters with or without an assistive device. * Cognitively intact based on scoring 18/22 or greater on the Montreal Cognitive Assessment (MoCA)-Blind during a phone screening process * Have access to an Android or iOS smartphone * Intermediate or high risk of falling, based on World Guidelines for Falls Prevention (Montero-Odasso et al, 2022) Exclusion Criteria: * Lower limb amputation * Visual impairment uncorrectable with lenses * Uncontrolled hypertension, diabetes, neurological or musculoskeletal impairment * Persistent symptoms of dizziness or lightheadedness * Spine or lower-extremity surgery in the past 12 months * Self-reported pain of \>7 on a scale of 0-10

Contact & Investigator

Central Contact

Vipul Lugade, PhD

✉ vlugade@binghamton.edu

📞 16077774700

Frequently Asked Questions

Who can join the NCT07433153 clinical trial?

This trial is open to participants of all sexes, aged 55 Years or older, studying Frail Elderly. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07433153 currently recruiting?

Yes, NCT07433153 is actively recruiting participants. Contact the research team at vlugade@binghamton.edu for enrollment information.

Where is the NCT07433153 trial being conducted?

This trial is being conducted at Binghamton, United States.

Who is sponsoring the NCT07433153 clinical trial?

NCT07433153 is sponsored by Binghamton University. The trial plans to enroll 36 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology